Ceribell Forecasts 2026 Revenue and CMS Delirium NTAP Finalization

Ceribell anticipates 2026 revenue between $114 million and $117 million, as the Centers for Medicare & Medicaid Services (CMS) finalizes its New Technology Add-on Payment (NTAP) for delirium, potentially reaching up to $2,171 per patient.